Iranian Pediatric Hematology and Oncology Society Iranian Journal of Blood and Cancer 2008-4595 3 3 2011 5 1 WHO Recommendations for the production, control and regulation of human plasma for fractionation 0 0 EN

Iranian Pediatric Hematology and Oncology Society Iranian Journal of Blood and Cancer 2008-4595 3 3 2011 5 1 Securing Safe Plasma for Fractionation the Duty of any Country 0 0 EN

Iranian Pediatric Hematology and Oncology Society Iranian Journal of Blood and Cancer 2008-4595 3 3 2011 5 1 Pathogen Reduction of Plasma 0 0 EN

Iranian Pediatric Hematology and Oncology Society Iranian Journal of Blood and Cancer 2008-4595 3 3 2011 5 1 Plasma Fractionation Industry Project in Turkey: Country’s Experiences 0 0 EN

Iranian Pediatric Hematology and Oncology Society Iranian Journal of Blood and Cancer 2008-4595 3 3 2011 5 1 Patients Perspective in Plasma Products (Focus on Hemophilia) 0 0 EN

Iranian Pediatric Hematology and Oncology Society Iranian Journal of Blood and Cancer 2008-4595 3 3 2011 5 1 Clinical application of plasma derived medicines: current situation and future trend 0 0 EN

Iranian Pediatric Hematology and Oncology Society Iranian Journal of Blood and Cancer 2008-4595 3 3 2011 5 1 Access and Rational use of Plasma Protein Therapies (PPTs) 0 0 EN

Iranian Pediatric Hematology and Oncology Society Iranian Journal of Blood and Cancer 2008-4595 3 3 2011 5 1 Hyperimmunes Plasma Procurement and Products 0 0 EN

Iranian Pediatric Hematology and Oncology Society Iranian Journal of Blood and Cancer 2008-4595 3 3 2011 5 1 Quality Assurance and Good Manufacturing Practice in Respect of Plasma Fractionation 0 0 EN

Iranian Pediatric Hematology and Oncology Society Iranian Journal of Blood and Cancer 2008-4595 3 3 2011 5 1 Plasma derived versus biotechnological manufactured medicine 0 0 EN

Iranian Pediatric Hematology and Oncology Society Iranian Journal of Blood and Cancer 2008-4595 3 3 2011 5 1 Making plasma derived medicines available 0 0 EN

Iranian Pediatric Hematology and Oncology Society Iranian Journal of Blood and Cancer 2008-4595 3 3 2011 5 1 Worldwide Supply and Demand of Plasma And Plasma-Derived Medicines 0 0 EN

Iranian Pediatric Hematology and Oncology Society Iranian Journal of Blood and Cancer 2008-4595 3 3 2011 5 1 Plasma Fractionation in Malaysia 0 0 EN

Iranian Pediatric Hematology and Oncology Society Iranian Journal of Blood and Cancer 2008-4595 3 3 2011 5 1 Self Sufficiency In Plasma And Plasma Derived Medicines 0 0 EN

Iranian Pediatric Hematology and Oncology Society Iranian Journal of Blood and Cancer 2008-4595 3 3 2011 5 1 Message of President of ISBT to 2nd International Conference on Transfusion Medicine/Plasma Industry in Tehran, Iran, May 10-11, 2011 0 0 EN